These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6724128)

  • 21. [Use of buflomedil hydrochloride in ocular pathology].
    Campinchi R; Schmitt A
    Bull Soc Ophtalmol Fr; 1981; 81(4-5):413-4. PubMed ID: 7261227
    [No Abstract]   [Full Text] [Related]  

  • 22. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract]   [Full Text] [Related]  

  • 23. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Ralli L; Guerrini M; Di Perri T
    J Int Med Res; 1984; 12(3):188-92. PubMed ID: 6734922
    [No Abstract]   [Full Text] [Related]  

  • 24. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P; Pagratis N
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of long-term administration of buflomedil on regional cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Okada K; Kitani M; Yamashita K; Shimote K; Tsunematsu T
    Angiology; 1988 Nov; 39(11):934-41. PubMed ID: 3177960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease.
    Mannarino E; Pasqualini L; Maragoni G; Orlandi U
    Angiology; 1989 Jun; 40(6):559-62. PubMed ID: 2719340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical, oscillographic and plethysmographic comparison before and after medical and surgical treatment of subjects with peripheral obliterating arteriopathy].
    Tardito E; Grassi T
    Minerva Med; 1971 May; 62(39):1971-80. PubMed ID: 5579735
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of buflomedil in vascular radiology of hepatoma].
    Emery JC; Genin G; Bonvoisin S; Croisille M
    Ann Radiol (Paris); 1994; 37(6):441-8. PubMed ID: 7702337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
    Bachir D; Maurel A; Beuzard Y; Razavian M; Kraiem A; Portos JL; Galacteros F
    Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs].
    Allegra C; Andreozzi GM; Avellone G; Cospite M; Del Guercio R; Lepore R; Nuzzaci G; Pinto A; Romeo S
    Clin Ter; 1986 Oct; 119(1):25-33. PubMed ID: 3539466
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
    Demichelis Genesio MA; Sanz MC
    Angiology; 1981 Oct; 32(10):717-28. PubMed ID: 7034593
    [No Abstract]   [Full Text] [Related]  

  • 33. The pharmacological effects of buflomedil in patients with multi-cerebral infarcts dementia: an open, preliminary assessment.
    Karoutas G; Milonas I; Artemis N; Karacostas D; Pitas J; Logothetis J
    Curr Med Res Opin; 1987; 10(6):380-9. PubMed ID: 3568750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in erythrocyte ATP after the oral administration of buflomedil hydrochloride].
    Briguglio F; Briguglio E; Di Marco V; Circosta C; Trozzi A
    Minerva Med; 1987 Apr; 78(8):553-6. PubMed ID: 3574742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
    Savagnone E; Sunseri V
    Minerva Cardioangiol; 1985 Nov; 33(11):757-64. PubMed ID: 4088478
    [No Abstract]   [Full Text] [Related]  

  • 36. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study.
    Ducrey N; Curchod B
    J Int Med Res; 1984; 12(3):184-7. PubMed ID: 6734921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of buflomedil in the treatment of post-traumatic cerebral edema].
    Urciuoli R; Reggio S
    Agressologie; 1988 May; 29(6):469-71. PubMed ID: 3213896
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
    Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P; Maurel A
    Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.